1. Home
  2. MS vs NVS Comparison

MS vs NVS Comparison

Compare MS & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Morgan Stanley

MS

Morgan Stanley

HOLD

Current Price

$174.67

Market Cap

242.4B

Sector

Finance

ML Signal

HOLD

Logo Novartis AG

NVS

Novartis AG

HOLD

Current Price

$132.33

Market Cap

254.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MS
NVS
Founded
1924
1895
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
242.4B
254.8B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
MS
NVS
Price
$174.67
$132.33
Analyst Decision
Buy
Sell
Analyst Count
15
3
Target Price
$167.38
$118.00
AVG Volume (30 Days)
5.5M
1.6M
Earning Date
01-15-2026
10-28-2025
Dividend Yield
2.29%
1.96%
EPS Growth
48.48
N/A
EPS
9.75
7.30
Revenue
$68,532,000,000.00
$56,372,000,000.00
Revenue This Year
$17.60
$9.33
Revenue Next Year
$5.64
$2.75
P/E Ratio
$17.94
$18.14
Revenue Growth
17.59
12.88
52 Week Low
$94.33
$96.06
52 Week High
$176.00
$134.24

Technical Indicators

Market Signals
Indicator
MS
NVS
Relative Strength Index (RSI) 67.94 57.93
Support Level $168.10 $128.91
Resistance Level $170.27 $134.24
Average True Range (ATR) 4.14 1.77
MACD 1.06 0.47
Stochastic Oscillator 94.58 82.41

Price Performance

Historical Comparison
MS
NVS

About MS Morgan Stanley

Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 80,000 employees as of year-end 2024. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $7.9 trillion in client assets at the end of its most recent fiscal year. After reincorporation as a bank holding company in the wake of the great financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with nearly $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.

About NVS Novartis AG

Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Share on Social Networks: